Gut Colonization of Healthy Children and Their Mothers With Pathogenic Ciprofloxacin-Resistant Escherichia coli

J Infect Dis. 2015 Dec 15;212(12):1862-8. doi: 10.1093/infdis/jiv278. Epub 2015 May 12.

Abstract

Background: The reservoir of pathogenic ciprofloxacin-resistant Escherichia coli remains unknown.

Methods: We conducted a prospective cohort study of 80 healthy twins and their mothers to determine the frequency of excretion of ciprofloxacin-resistant, potentially pathogenic E. coli. Stool specimens were cultured selectively for ciprofloxacin-resistant gram-negative bacteria. Isolates were categorized on the basis of additional resistance and virulence profiles. We also prospectively collected clinical metadata.

Results: Fifteen children (19%) and 8 mothers (20%) excreted ciprofloxacin-resistant E. coli at least once. Overall, 33% of 40 families had at least 1 member whose stool specimen yielded ciprofloxacin-resistant E. coli on culture. Fifty-seven submitted stool specimens (2.8%) contained such organisms; clones ST131-H30 and ST405 accounted for 52 and 5 of the positive specimens, respectively. Length of hospital stay after birth (P = .002) and maternal colonization (P = .0001) were associated with subsequent childhood carriage of ciprofloxacin-resistant E. coli; antibiotic use, acid suppression, sex, mode of delivery, and maternal perinatal antibiotic use were not. Ciprofloxacin-resistant E. coli were usually resistant to additional antibiotic classes, and all had virulence genotypes typical of extraintestinal pathogenic E. coli.

Conclusions: Healthy children and their mothers commonly harbor ciprofloxacin-resistant E. coli with pathogenic potential.

Keywords: E. coli ST131-H30; E. coli ST405; ciprofloxacin-resistant E. coli; extra-intestinal pathogenic E. coli; urinary tract infections.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology*
  • Carrier State / epidemiology
  • Carrier State / microbiology*
  • Child, Preschool
  • Ciprofloxacin / pharmacology*
  • Drug Resistance, Bacterial*
  • Escherichia coli / drug effects*
  • Escherichia coli / isolation & purification
  • Escherichia coli Infections / epidemiology
  • Escherichia coli Infections / microbiology*
  • Feces / microbiology
  • Female
  • Gastrointestinal Tract / microbiology*
  • Genotype
  • Healthy Volunteers
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Molecular Typing
  • Pregnancy
  • Prevalence
  • Prospective Studies

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin